CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to NoteZacks Investment Research • Friday
CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • Tuesday
CRISPR Therapeutics (CRSP) Moves 9.2% Higher: Will This Strength Last?Zacks Investment Research • 07/17/24
Here's Why CRISPR Therapeutics AG (CRSP) Gained But Lagged the Market TodayZacks Investment Research • 07/10/24
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued.The Motley Fool • 06/27/24